Gastroenteropancreatic neuroendocrine neoplasms: genes, therapies and models

K Kawasaki, M Fujii, T Sato - Disease models & …, 2018 - journals.biologists.com
Gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs) refer to a group of
heterogeneous cancers of neuroendocrine cell phenotype that mainly fall into one of two …

The role of cell lines in the study of neuroendocrine tumors

S Grozinsky-Glasberg, I Shimon, H Rubinfeld - Neuroendocrinology, 2012 - karger.com
Cell lines originating from neuroendocrine tumors (NETs) represent useful experimental
models to assess the control of synthesis and release of different hormones and hormone …

[HTML][HTML] The neuroendocrine phenotype, genomic profile and therapeutic sensitivity of GEPNET cell lines

T Hofving, Y Arvidsson, B Almobarak… - Endocrine-related …, 2018 - erc.bioscientifica.com
Experimental models of neuroendocrine tumour disease are scarce, and no comprehensive
characterisation of existing gastroenteropancreatic neuroendocrine tumour (GEPNET) cell …

[HTML][HTML] EZH2 presents a therapeutic target for neuroendocrine tumors of the small intestine

E Barazeghi, P Hellman, O Norlén, G Westin… - Scientific Reports, 2021 - nature.com
Small intestinal neuroendocrine tumors (SI-NETs) are slow-growing tumors that seem
genetically quite stable without highly recurrent mutations, but are epigenetically …

[PDF][PDF] High-resolution genomic profiling reveals gain of chromosome 14 as a predictor of poor outcome in ileal carcinoids

E Andersson, C Swärd, G Stenman… - Endocrine-related …, 2009 - researchgate.net
Ileal carcinoids are malignant neuroendocrine tumours of the small intestine. The aim of this
study was to obtain a high-resolution genomic profile of ileal carcinoids in order to define …

Identification of cancer stem cells in human gastrointestinal carcinoid and neuroendocrine tumors

P Gaur, EL Sceusi, S Samuel, L Xia, F Fan, Y Zhou… - Gastroenterology, 2011 - Elsevier
BACKGROUND & AIMS: Metastatic gastrointestinal neuroendocrine tumors (NETs)
frequently are refractory to chemotherapy. Chemoresistance in various malignancies has …

Global hypomethylation and promoter methylation in small intestinal neuroendocrine tumors: an in vivo and in vitro study

O Fotouhi, M Adel Fahmideh, M Kjellman, L Sulaiman… - Epigenetics, 2014 - Taylor & Francis
Aberrant DNA methylation is a feature of human cancer affecting gene expression and tumor
phenotype. Here, we quantified promoter methylation of candidate genes and global …

QGP-1 cells release 5-HT via TRPA1 activation; a model of human enterochromaffin cells

H Doihara, K Nozawa, R Kojima… - Molecular and cellular …, 2009 - Springer
Recently, we discovered that transient receptor potential ankyrin1 channel (TRPA1) is highly
expressed in human and rat enterochromaffin (EC) cells, and those TRPA1 agonists such as …

[HTML][HTML] Preclinical models of neuroendocrine neoplasia

AJH Sedlack, K Saleh-Anaraki, S Kumar, PH Ear… - Cancers, 2022 - mdpi.com
Simple Summary Neuroendocrine neoplasia comprise many distinct and rare subtypes of
cancers. Preclinical models are essential for improving understanding of these diseases …

[HTML][HTML] Down-regulation of miR-129-5p and the let-7 family in neuroendocrine tumors and metastases leads to up-regulation of their targets Egr1, G3bp1, Hmga2 and …

KBV Døssing, T Binderup, B Kaczkowski, A Jacobsen… - Genes, 2014 - mdpi.com
Expression of miRNAs in Neuroendocrine Neoplasms (NEN) is poorly characterized. We
therefore wanted to examine the miRNA expression in Neuroendocrine Tumors (NETs), and …